Jennifer Ruddock | Senior Vice President, Strategy and Corporate Affairs |
Howard Robin | President and Chief Executive Officer |
Dr. Wei Lin | Senior Vice President and Head of Development |
Dr. Jonathan Zalevsky | Chief Research and Development Officer |
Gil Labrucherie | Chief Operating Officer and Chief Financial Officer |
Chris Shibutani | Cowen |
Alexander Duncan | Piper Sandler |
Jessica Fye | JP Morgan |
Bert Hazlett | BTIG |
Paul Choi | Goldman Sachs |
George Farmer | BMO Capital Markets |
Jay Olson | Oppenheimer |
Arlinda Lee | Canaccord |
Andy Hseih | William Blair |
Daina Graybosch | SVB Leerink |
Ladies and gentlemen, thank you for standing by, and welcome to the Nektar Therapeutics Fourth Quarter 2019 Financial Results Conference. [Operator Instructions]
I would now like to hand the conference over to your speaker today, Ms. Jennifer Ruddock, Head of Corporate Affairs. Ma'am, you may begin.